Press Releases
Feb. 16, 2026
Gov. Spencer J. Cox’s Schedule: Feb. 16 – Feb. 21, 2026
Gov't Institution
Governor of Utah
Owner: American Government
Feb. 4, 2026
TRM Labs Announces $70M Series C to Scale AI Solutions to Disrupt Criminal Networks and Counter National Security Threats
Indeterminate
GlobeNewswire, Inc.
Feb. 4, 2026
Dr. Avis D. Dickey Releases Stellar Leadership: Igniting Excellence Beyond the C-Suite
Neutral
EIN Presswire
Feb. 4, 2026
Right Toyota Funds Grant Supporting 'Home for Hope' Initiative Through The C.A.R.E. Organization
Neutral
EIN Presswire
Feb. 4, 2026
SCOR January 2026 P&C Reinsurance Renewals: Selective growth in a competitive pricing environment
Indeterminate
GlobeNewswire, Inc.
8 hours ago
Zimmermann Modern Wellness Launches IV Wellness Program
Neutral
EIN Presswire
Feb. 14, 2026
As Starlink Builds Momentum, One Tech Expert’s Video Presentation Says There’s One Overlooked Company Worth Watching
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
Indeterminate
GlobeNewswire, Inc.
Feb. 2, 2026
H.H.C. Group Releases White Paper on Independent Reviews in an AI-Driven Claims Environment
Indeterminate
GlobeNewswire, Inc.
Feb. 14, 2026
Whitehouse, Senate Democrats Investigate EPA’s “Fait Accompli” Repeal of Bedrock Climate Safeguard
Gov't Institution
U.S. Senate Committee on Environment and Public Works
Owner: American Government
Feb. 14, 2026
NCLA Backs HUD’s Rescinding Disparate Impact Liability Rule that Fair Housing Act Never Supported
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
District Man Pleads Guilty to Second-Degree Murder Charge
Gov't Institution
The U.S. Attorney's Office District of Puerto Rico
Owner: American Government
Feb. 13, 2026
Twelfth and Final Member of ‘21st and Vietnam’ Crew Sentenced to 101 Months on Narcotics, Weapons Counts
Gov't Institution
The U.S. Attorney's Office District of Puerto Rico
Owner: American Government
Jan. 28, 2026
OKYO Pharma Announces Successful Type C Meeting with the FDA
Indeterminate
GlobeNewswire, Inc.